# Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients

> **NCT03647462** · NA · UNKNOWN · sponsor: **Kaiser Permanente** · enrollment: 100 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DEVICE:** Continuous Positive Airway Pressure

## Key facts

- **NCT ID:** NCT03647462
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06
- **Primary completion:** 2024-09
- **Final completion:** 2025-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03647462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03647462, "Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03647462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*